SUSTAINED RELEASE DELIVERY OF REPAGLINIDE BY BIODEGRADABLE MICROSPHERES
Abstract
The primary objective of the present study was to prepare repaglinide microspheres for the sustained delivery of the drug for better patient care in the management of diabetics. The biodegradable microspheres of repaglinide is prepare using poly (lactic-co-glycolic acid) (PLGA) by emulsion solvent evaporation technique. The microspheres are prepared with different drug-to-carrier ratios and considering other variables (i.e. solvent, surfactant and stirrer speed) as well. The evaluation of microspheres prepared are perform on the basis of various parameters like particle size, percentage yield, drug entrapment efficiency, surface morphology, drug-polymer interaction (FT-IR study), in vitro drug release kinetics and stability studies. SEM reveals that microspheres are spherical and has nearly smooth surface morphology. The percentage yield and drug entrapment efficiency is quite well for all the formulations. FT-IR spectra show that there is no chemical interaction between the drug and the polymer. The in vitro release study data shows that the repaglinide release from all the formulations are slow and sustained upto 7days. The various kinetic equations indicate that the in vitro drug release is of zero order release with initial burst from repaglinide microspheres. There is no appreciable difference is observed in the stability study observations.
DOI
https://doi.org/10.22270/jddt.v7i7.1593References
Chowdary KPR, Koteswara N, Malathi K, Ethyl cellulose microspheres of glipizide: Characterization, in vitro and in vivo evaluation, IJP, 2004, 66, 412-6.
Singh D, Saraf S, Dixit VK, Saraf S, Formulation optimization of gentamicin loaded Eudragit RS100 microspheres using factorial design study, BPB, 2008, 31, 662-7.
Jain SK, Agrawal GP, Jain NK, A novel calcium silicate based microspheres of repaglinide: in vivo investigations, JCR, 2006, 113,111-6.
Haznedar S, Dortunc B, Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide, IJP, 2004, 269, 131-40.
Published
Abstract Display: 411 
PDF Downloads: 537 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.